Microglandular adenosis or microglandular adenoma? A molecular genetic analysis of a case associated with atypia and invasive carcinoma

Histopathology

Volumn 55, Issue 6, 2009, Pages 732-743

  Geyer, Felipe C ^a   Kushner, Yael B ^b   Lambros, Maryou B ^a   Natrajan, Rachael ^a   MacKay, Alan ^a   Tamber, Narinder ^a   Fenwick, Kerry ^a   Purnell, Dave ^c   Ashworth, Alan ^a   Walker, Rosemary A ^d   Reis Filho, Jorge S ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^b MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^c UNIVERSITY HOSPITALS OF LEICESTER NHS TRUST   (United Kingdom)

^d UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

Basal like; Breast cancer; Comparative genomic hybridization; Microglandular adenosis; Triple negative

Indexed keywords

AGED; ARTICLE; BREAST LESION; CANCER GRADING; CASE REPORT; CHROMOSOME ABERRATION; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENETIC ANALYSIS; GENOMIC IN SITU HYBRIDIZATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOCHEMISTRY; INTRADUCTAL CARCINOMA; INVASIVE CARCINOMA; MICROGLANDULAR ADENOSIS; MOLECULAR GENETICS; PRIORITY JOURNAL;

ADENOMA; AGED; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; DIAGNOSIS, DIFFERENTIAL; FEMALE; FIBROCYSTIC BREAST DISEASE; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 70849135676     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2009.03432.x     Document Type: Article

References (31)

1. McDivitt RW, Stewart FW, Berg GW (eds). Tumours of the breast. Washington, DC : Armed Forces Institute of Pathology, 1968.
2. Eusebi V, Foschini MP, Betts CM et al. Microglandular adenosis, apocrine adenosis, and tubular carcinoma of the breast. An immunohistochemical comparison. Am. J. Surg. Pathol. 1993 17 99 109.
3. Koenig C, Dadmanesh F, Bratthauer GL, Tavassoli FA. Carcinoma arising in microglandular adenosis: an immunohistochemical analysis of 20 intraepithelial and invasive neoplasms. Int. J. Surg. Pathol. 2000 8 303 315.
4. Tavassoli FA, Norris HJ. Microglandular adenosis of the breast. A clinicopathologic study of 11 cases with ultrastructural observations. Am. J. Surg. Pathol. 1983 7 731 737.
5. Rosenblum MK, Purrazzella R, Rosen PP. Is microglandular adenosis a precancerous disease? A study of carcinoma arising therein Am. J. Surg. Pathol. 1986 10 237 245.
6. Acs G, Simpson JF, Bleiweiss IJ et al. Microglandular adenosis with transition into adenoid cystic carcinoma of the breast. Am. J. Surg. Pathol. 2003 27 1052 1060.
7. Kay S. Microglandular adenosis of the female mammary gland: study of a case with ultrastructural observations. Hum. Pathol. 1985 16 637 641.
8. Khalifeh IM, Albarracin C, Diaz LK et al. Clinical, histopathologic, and immunohistochemical features of microglandular adenosis and transition into in situ and invasive carcinoma. Am. J. Surg. Pathol. 2008 32 544 552.
9. Rosen PP. Microglandular adenosis. A benign lesion simulating invasive mammary carcinoma. Am. J. Surg. Pathol. 1983 7 137 144.
10. Gusterson B. Do 'basal-like' breast cancers really exist? Nat. Rev. Cancer 2009 9 128 134.
11. Shin SJ, Simpson PT, Da Silva L et al. Molecular evidence for progression of microglandular adenosis (MGA) to invasive carcinoma. Am. J. Surg. Pathol. 2009 33 496 504.
12. Arriola E, Lambros MB, Jones C et al. Evaluation of Phi29-based whole-genome amplification for microarray-based comparative genomic hybridisation. Lab. Invest. 2007 87 75 83. (Pubitemid 44973656)
13. Marchio C, Iravani M, Natrajan R et al. Genomic and immunophenotypical characterization of pure micropapillary carcinomas of the breast. J. Pathol. 2008 215 398 410.
14. Coe BP, Ylstra B, Carvalho B et al. Resolving the resolution of array CGH. Genomics 2007 89 647 653.
15. Tan DS, Lambros MB, Natrajan R, Reis-Filho JS. Getting it right: designing microarray (and not 'microawry') comparative genomic hybridization studies for cancer research. Lab. Invest. 2007 87 737 754.
16. Reis-Filho JS, Drury S, Lambros MB et al. ESR1 gene amplification in breast cancer: a common phenomenon? Nat. Genet. 2008 40 809 810.
17. Lambros MB, Simpson PT, Jones C et al. Unlocking pathology archives for molecular genetic studies: a reliable method to generate probes for chromogenic and fluorescent in situ hybridization. Lab. Invest. 2006 86 398 408.
18. Reis-Filho JS, Natrajan R, Vatcheva R et al. Is acinic cell carcinoma a variant of secretory carcinoma? A FISH study using ETV6 'split apart' probes Histopathology 2008 52 840 846.
19. Tan DS, Marchio C, Jones RL et al. Triple negative breast cancer: molecular profiling and prognostic impact in adjuvant anthracycline-treated patients. Breast Cancer Res. Treat. 2008 111 27 44.
20. Wolff AC, Hammond ME, Schwartz JN et al. American society of clinical oncology/college of American pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. J. Clin. Oncol. 2007 25 118 145.
21. Parry S, Savage K, Marchio C, Reis-Filho JS. Nestin is expressed in basal-like and triple negative breast cancers. J. Clin. Pathol. 2008 61 1045 1050.
22. Savage K, Lambros MB, Robertson D et al. Caveolin 1 is overexpressed and amplified in a subset of basal-like and metaplastic breast carcinomas: a morphologic, ultrastructural, immunohistochemical, and in situ hybridization analysis. Clin. Cancer Res. 2007 13 90 101.
23. Savage K, Leung S, Todd SK et al. Distribution and significance of caveolin 2 expression in normal breast and invasive breast cancer: an immunofluorescence and immunohistochemical analysis. Breast Cancer Res. Treat. 2008 110 245 256.
24. Tognon C, Knezevich SR, Huntsman D et al. Expression of the ETV6-NTRK3 gene fusion as a primary event in human secretory breast carcinoma. Cancer Cell 2002 2 367 376.
25. Rosen P (ed Rosen's breast pathology, 2nd edn. Philadelphia : Lippincott Williams & Wilkins, 2001.
26. Abdel-Fatah TM, Powe DG, Hodi Z et al. High frequency of coexistence of columnar cell lesions, lobular neoplasia, and low grade ductal carcinoma in situ with invasive tubular carcinoma and invasive lobular carcinoma. Am. J. Surg. Pathol. 2007 31 417 426.
27. Simpson PT, Reis-Filho JS, Gale T, Lakhani SR. Molecular evolution of breast cancer. J. Pathol. 2005 205 248 254.
28. Fulford LG, Easton DF, Reis-Filho JS et al. Specific morphological features predictive for the basal phenotype in grade 3 invasive ductal carcinoma of breast. Histopathology 2006 49 22 34.
29. Reis-Filho JS, Milanezi F, Steele D et al. Metaplastic breast carcinomas are basal-like tumours. Histopathology 2006 49 10 21.
30. Weigelt B, Horlings HM, Kreike B et al. Refinement of breast cancer classification by molecular characterization of histological special types. J. Pathol. 2008 216 141 150.
31. Weigelt B, Kreike B, Reis-Filho JS. Metaplastic breast carcinomas are basal-like breast cancers: a genomic profiling analysis. Breast Cancer Res. Treat. 2009 117 273 280.